DE116622C - - Google Patents
Info
- Publication number
- DE116622C DE116622C DENDAT116622D DE116622DA DE116622C DE 116622 C DE116622 C DE 116622C DE NDAT116622 D DENDAT116622 D DE NDAT116622D DE 116622D A DE116622D A DE 116622DA DE 116622 C DE116622 C DE 116622C
- Authority
- DE
- Germany
- Prior art keywords
- blood
- animals
- aphthous
- serum
- contents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000004369 blood Anatomy 0.000 claims description 18
- 239000008280 blood Substances 0.000 claims description 18
- 241001465754 Metazoa Species 0.000 claims description 12
- 239000003053 toxin Substances 0.000 claims description 10
- 231100000765 toxin Toxicity 0.000 claims description 10
- 210000002966 serum Anatomy 0.000 claims description 6
- 208000007212 Foot-and-Mouth Disease Diseases 0.000 claims description 5
- 241000710198 Foot-and-mouth disease virus Species 0.000 claims description 5
- 230000003053 immunization Effects 0.000 claims description 5
- 241001494479 Pecora Species 0.000 claims description 4
- 208000002399 aphthous stomatitis Diseases 0.000 claims description 4
- 241000282887 Suidae Species 0.000 claims description 3
- 238000002649 immunization Methods 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 206010037660 Pyrexia Diseases 0.000 claims description 2
- 244000309464 bull Species 0.000 claims description 2
- 238000002474 experimental method Methods 0.000 claims description 2
- 238000002347 injection Methods 0.000 claims description 2
- 239000007924 injection Substances 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 230000000069 prophylactic effect Effects 0.000 claims description 2
- 230000001018 virulence Effects 0.000 claims description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 2
- 238000002255 vaccination Methods 0.000 claims 2
- 241000283699 Bos indicus Species 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000011521 glass Substances 0.000 claims 1
- 235000011187 glycerol Nutrition 0.000 claims 1
- 239000003223 protective agent Substances 0.000 claims 1
- 230000001681 protective effect Effects 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- 238000010792 warming Methods 0.000 claims 1
- 108700012359 toxins Proteins 0.000 description 9
- 208000015181 infectious disease Diseases 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 210000002751 lymph Anatomy 0.000 description 2
- 241000283707 Capra Species 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 208000020670 canker sore Diseases 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1009—Picornaviridae, e.g. hepatitis A virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE116622C true DE116622C (enrdf_load_stackoverflow) |
Family
ID=385953
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DENDAT116622D Active DE116622C (enrdf_load_stackoverflow) |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE116622C (enrdf_load_stackoverflow) |
-
0
- DE DENDAT116622D patent/DE116622C/de active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Alton et al. | Rev. 1 Brucella melitensis vaccine: a review of ten years of study. | |
| Sandhu | Immunization of White Pekin ducklings against Pasteurella anatipestifer infection | |
| Bierer et al. | Immunologic response of turkeys to an avirulent Pasteurella multocida vaccine in the drinking water | |
| Sandhu | Immunogenicity and safety of a live Pasteurella anatipestifer vaccine in White Pekin ducklings: laboratory and field trials | |
| DE60111507T2 (de) | Polysaccharidkonjugate von pneumokokken als impfstoff gegen tetanus und diphterie | |
| Gear, James,* De Meillon, Botha,* Measroch, V.* & Davis | Rift valley fever in South Africa: 2: The occurrence of human cases in the orange free state, the north-western cape province, the western and southern transvaal: B: Field and laboratory investigations | |
| Cook et al. | A live attenuated turkey rhinotracheitis virus vaccine. 1. Stability of the attenuated strain | |
| DE69432665T2 (de) | Multikomponentenimpfstoff aus clostridien, der saponin als adjuvans benutzt | |
| DE2817299A1 (de) | Verfahren zur herstellung eines attenuierten infektioese-gastroenteritis (tge)-virusstammes zur anwendung in lebendvakzinen | |
| DE2717919A1 (de) | Verfahren zur herstellung eines pferde-rhinopneumonievakzins und durch dieses verfahren hergestelltes vakzin | |
| Hasenclever et al. | Immunization of mice against Listeria monocytogenes | |
| DE2816942C2 (de) | Impfstoff gegen Rhinitis atrophicans beim Schwein | |
| DE116622C (enrdf_load_stackoverflow) | ||
| DE2212277B2 (de) | Verfahren zur Herstellung einer Totvaccine gegen infektiöse atrophische Rhinitis der Schweine | |
| DE69231724T2 (de) | Fischimpfstoff gegen infektion mit aeromonas salmonicida | |
| DE833673C (de) | Verfahren zur Herstellung einer Schweinecholera-Lymphe | |
| DE2602478C3 (de) | Impfstoff gegen die Panleukopenie der Feliden | |
| Howell | Observations on the occurrence of African horsesickness amongst immunised horses | |
| DE3750725T2 (de) | GEMEINSAME IMPFUNG UNTER VERWENDUNG EINER PRAPARATION GRAM-NEGATIVER BAKTERIEN OHNE O-SPEZIFISCHEN KOHlEHYDRATSEITENKETTEN. | |
| Griffitts | Laboratory method of determining the potency of typhoid vaccine | |
| DE69208854T2 (de) | Impfstoff-Zubereitung zur Vorbeugung gegen bei Tieren durch Chlamydia psitacci verursachte Fehlgeburt | |
| Wright | Transmission of Toxoplasma gondil across the guinea-pig placenta | |
| O'reilly et al. | Infection of sheep and monkeys with Langat virus: cross-protection against other viruses of the Russian spring-summer complex | |
| Noguchi | ETIOLOGY OF YELLOW FEVER: IV. The Acquired Immunity of Guinea Pigs against Leptospira icteroides after the Inoculation of Blood of Yellow Fever Patients. | |
| Johnson et al. | Intracerebral infection of mice with ovine strains of Chlamydia psittaci: an animal screening test for the assay of vaccines |